GlobeNewswire by notified

ABN AMRO reports net profit of EUR 295 million in the first quarter

Share

ABN AMRO reports net profit of EUR 295 million in the first quarter

  • Net profit of EUR 295million; solid performance and loan growth
  • Costs higher due to additional AML provision and regulatory levies; remain fully committed to cost targetbelow EUR 4.7 billion in 2024
  • Credit quality remains strong; impairments reflect weakened macroeconomic outlook and potential second-order effects of the war in Ukraine
  • Mortgage market share increased to 17%;strong operational capabilities in competitive market
  • Strong capital position; Basel IIICET1 ratio of 15.7%(Basel IV around 16%), including a EUR 5 billion RWA add-on for model reviews and redevelopments
  • First share buyback programme of EUR 500 million finalised

In the first quarter of 2022, net profit was EUR 295 million. Net interest income was EUR 1,310 million, impacted by lower mortgage prepayment penalties and higher hedging costs. Fee income increased by 10% compared with Q1 2021, driven by higher asset management fee income and strong results at Clearing. Costs were higher due to an additional EUR 50 million AML provision and higher regulatory levies. Strategic investments remained elevated at the beginning of the year, as we continued to focus on implementing our new client service model.

Credit quality remains strong. Impairments in Q1 were EUR 62 million as a result of the updated macroeconomic scenarios. A management overlay for potential second-order effects of the war in Ukraine was offset by Covid-related releases. Risk-weighted assets increased by EUR 6.7 billion, mainly due to a EUR 5.0 billion add-on for model reviews and redevelopments. ABN AMRO’s capital position remains strong, with a fully-loaded Basel III CET1 ratio of 15.7% and a Basel IV CET1 ratio of around 16%, well above regulatory capital requirements.

Robert Swaak, CEO, comments:

Our world changed significantly in the last quarter. The war in Ukraine shook our sense of security and stability, causing further economic uncertainty and sharp inflation. We areextremely concerned about this conflict, which representsa direct assault on the principles of democracy and freedom. Our thoughts are with all those affected by the war and we aim to provide support where possible.
ABN AMRO’s direct exposure to Russia is very limited, but we expect potential second-order effectsto have an impact on our clients. We are closely monitoring the situation and proactively reaching out to clients.
Dutch society reopened fully in the first quarteras Covid restrictions were lifted and we saw the negative impact of the global pandemic decrease.Demand for credit was good and both the mortgage and corporate loan books grew.We delivered a solid performance in the first quarter.
We finalised our first EUR 500 million share buyback programme last week and remain committed to returning capital to shareholders.We are well on track towards meeting our targets in 2024 as we continue our journey as a personal bank in the digital age.

Key figures and indicators
(in EUR millions)
Q1 2022Q1 2021ChangeQ4 2021Change
Operating income 1,933 1,847 5% 2,284 -15%
Operating expenses 1,508 1,843 -18% 1,433 5%
Operating result 425 4 851 -50%
Impairment charges on financial instruments 62 -77 121 -49%
Income tax expenses 68 135 -50% 177 -62%
Profit/(loss) for the period 295 -54 552 -47%
Cost/income ratio 78.0% 99.8% 62.8%
Return on average Equity 5.4% -1.6% 10.8%
CET1 ratio 15.7% 17.4% 16.3%


ABN AMRO Press Office
Jarco de Swart
Senior Press Officer
pressrelations@nl.abnamro.com
+31 20 6288900
ABN AMRO Investor Relations
Ferdinand Vaandrager
Head of Investor Relations investorrelations@nl.abnamro.com
+31 20 6282282



This press release is published by ABN AMRO Bank N.V. and contains inside information within the meaning of article 7 (1) to (4) of Regulation (EU) No 596/2014 (Market Abuse Regulation)


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release

REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens

Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release

24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au

Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo

Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release

EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form